Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E-cigarette Nicotine Strength and Tobacco Substitution
NCT03843047Completed
- Sponsor
- Virginia Tech
- Start
- Mar 2019
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of nicotine in Tobacco Use Disorder (TUD) (2 arms), sponsored by Virginia Tech. Primary endpoint: E-liquid substitution at 1 day. Started Mar 2019; status: completed.
02
Drugs
nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT03843047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03843047.